Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Herlev Hospital
Xencor, Inc.
Emory University
OHSU Knight Cancer Institute
Sheba Medical Center
Northwestern University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Threshold Pharmaceuticals